Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lampalizumab (RG 7417) is a humanized monoclonal antibody targeting Complement Factor D in the complement pathway, used in age-related macular degeneration (AMD) and cardiovascular disease research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $263 | In Stock | |
5 mg | $795 | In Stock | |
10 mg | $1,260 | In Stock | |
25 mg | $1,870 | In Stock | |
50 mg | $2,520 | In Stock |
Description | Lampalizumab (RG 7417) is a humanized monoclonal antibody targeting Complement Factor D in the complement pathway, used in age-related macular degeneration (AMD) and cardiovascular disease research. |
In vivo | Lampalizumab achieved rapid equilibrium in eye tissue after intravitreal administration in cynomophagus monkeys. Its elimination is relatively slow in the eyes, τ1/2 in about 3 days, while the whole body is quickly eliminated, τ1/2 in 0.8 hours. [1] |
Alias | TNX234, TNX 234, RG7417, RG 7417, Anti-CFD Recombinant Antibody |
Molecular Weight | 46.96 (kDa) |
Cas No. | 1278466-20-8 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.